• For Researchers

Cancer Research Matters - Stigma, hope and TRACERx

This episode features our Chief Clinician Professor Charles Swanton. He talks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx. This episode features our Chief Clinician Professor Charles Swanton. He talks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx.

1 November 2022

• For Researchers

Cancer Research Matters - Side effects and sub-types

This episode features Professor Richard Gilbertson. Richard is a paediatric oncology clinician scientist and is the Director of the Cancer Research UK Cambridge Centre. He talks about the challenges and successes of the childhood cancer research community, how he sees the future of the field and some of the incredible breakthroughs his lab has made on childhood brain cancers. This episode features Professor Richard Gilbertson. Richard is a paediatric oncology clinician scientist and is the Director of the Cancer Research UK Cambridge Centre. He talks about the challenges and successes of the childhood cancer research community, how he sees the future of the field and some of the incredible breakthroughs his lab has made on childhood brain cancers.

6 September 2022

• For Researchers

Cancer Research Matters - Complexity and understanding

This episode features outgoing CRUK Chief Scientist, Professor Karen Vousden. Known for her work on the tumour suppressor protein, p53, she has also worked on HPV and cancer metabolism. She talks about the success and challenges of work around p53, her joy at being involved in the early work around HPV, the frustrations of coming so close to a huge breakthrough and how life as a researcher has changed. This episode features outgoing CRUK Chief Scientist, Professor Karen Vousden. Known for her work on the tumour suppressor protein, p53, she has also worked on HPV and cancer metabolism. She talks about the success and challenges of work around p53, her joy at being involved in the early work around HPV, the frustrations of coming so close to a huge breakthrough and how life as a researcher has changed.

25 August 2022

• For Researchers

Cancer Research Matters - The creative act of science

This episode features CRUK Chairman, Professor Sir Leszek Borysiewicz. Following a distinguished academic and clinical research career, Leszek’s roles have included Chief Executive of the Medical Research Council and Vice Chancellor of the University of Cambridge. He talks about the development of the HPV vaccine, the difficulties of navigating a research career and why we must start to embrace failure… even a negative result, he says, is positive. This episode features CRUK Chairman, Professor Sir Leszek Borysiewicz. Following a distinguished academic and clinical research career, Leszek’s roles have included Chief Executive of the Medical Research Council and Vice Chancellor of the University of Cambridge. He talks about the development of the HPV vaccine, the difficulties of navigating a research career and why we must start to embrace failure… even a negative result, he says, is positive.

20 July 2022

• Science & Technology
• Health & Medicine

Why haven't we cured cancer? - That Cancer Conversation podcast

This latest episode features 3 guests who explore why the idea of a cancer cure is so complex, but why there is still so much to be hopeful about. This latest episode features 3 guests who explore why the idea of a cancer cure is so complex, but why there is still so much to be hopeful about.

14 June 2022

• For Researchers

Cancer Research Matters - Microenvironments and early detection

This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic. This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic.

23 May 2022

• For Researchers

Cancer Research Matters - Translation tales

The episode features Steve Jackson. Steve is the University of Cambridge Frederick James Quick Professor of Biology. He is also Head of Cancer Research UK Laboratories at the Wellcome Trust/Cancer Research UK Gurdon Institute. He talks about the difference between academic and commercial science, tips for forming a spinout company and what we should aim for in the next 20 years of cancer research. The episode features Steve Jackson. Steve is the University of Cambridge Frederick James Quick Professor of Biology. He is also Head of Cancer Research UK Laboratories at the Wellcome Trust/Cancer Research UK Gurdon Institute. He talks about the difference between academic and commercial science, tips for forming a spinout company and what we should aim for in the next 20 years of cancer research.

23 March 2022

• For Researchers

Cancer Research Matters - A PARPing success

The first episode features Ruth Plummer. Ruth is Professor of Experimental Cancer Medicine at Newcastle University and Director of the CRUK Newcastle Cancer Centre. She talks about how the DNA repair inhibition field has changed over 20 years, her instrumental role in the development of the PARP inhibitor Rucaparib and why work/life balance is so important for the future of research life. The first episode features Ruth Plummer. Ruth is Professor of Experimental Cancer Medicine at Newcastle University and Director of the CRUK Newcastle Cancer Centre. She talks about how the DNA repair inhibition field has changed over 20 years, her instrumental role in the development of the PARP inhibitor Rucaparib and why work/life balance is so important for the future of research life.

4 February 2022

• Health & Medicine

The vaccination of a generation? - That Cancer Conversation podcast

Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer. Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer.

9 December 2021

• Science & Technology

Black in Cancer – That Cancer Conversation

From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer. From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer.

8 October 2021

• Science & Technology
• Health & Medicine

Can we grow the treatments of tomorrow? – That Cancer Conversation podcast

Find out how the chemistry inside plants can lead to life-changing drugs and how a cannabis-derived drug is part of a new trial to help people with a type of aggressive brain cancer. Find out how the chemistry inside plants can lead to life-changing drugs and how a cannabis-derived drug is part of a new trial to help people with a type of aggressive brain cancer.

2 September 2021

• Health & Medicine

'Will cancer make me infertile?' – That Cancer Conversation podcast

For the first episode of our new podcast, we explore cancer and infertility. For the first episode of our new podcast, we explore cancer and infertility.

12 May 2021